{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:02:18Z","timestamp":1785682938158,"version":"3.56.0"},"reference-count":21,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1996,2]]},"abstract":"<jats:p>The protein encoded by the p53 tumour suppressor gene plays an important part in the regulation of cell growth. Abnormalities of this gene represent one of the most common genetic changes in the development of human cancers. This study investigated the expression of p53 protein in cholangiocarcinoma arising in association with primary sclerosing cholangitis (PSC). Of the 14 patients with cholangiocarcinoma studied, 13 had underlying PSC. The expression of p53 protein was detected immunohistochemically in paraffin wax embedded liver specimens, after microwave pretreatment. The expression of p53 protein was shown in the cholangiocarcinoma tissue of 11 of 14 (78.5%) patients. In five of 10 patients, the accumulation of p53 protein highlighted the presence of neoplastic cells in biliary tissue separate from the main tumour. These cells were mainly located in the septal bile ducts or in the accessory glands, or both, but occasionally also in large portal areas at the periphery of nerves and lymphatics, and in one case in the mucosa of an extrahepatic bile duct. No p53 protein was detectable in liver tissue obtained at the time of transplantation in 15 patients with PSC but not cholangiocarcinoma. These results show that cholangiocarcinoma development in PSC is commonly associated with abnormalities of p53 and that these occur at a late stage in the development of the malignant process. Staining for p53 protein could represent an additional criterion for the diagnosis of cholangiocarcinoma development in patients with PSC.<\/jats:p>","DOI":"10.1136\/gut.38.2.265","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"265-268","source":"Crossref","is-referenced-by-count":49,"title":["p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis."],"prefix":"10.1136","volume":"38","author":[{"given":"P M","family":"Rizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S D","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Portmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J K","family":"Ramage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N V","family":"Naoumov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1996,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/351453a0","article-title":"The p53 tumour suppressor gene","volume":"351","author":"Levine, A.J.; Momand, J.; Finlay, C.A.","year":"1991","unstructured":"Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991; 351: 453-6.","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/362786a0","article-title":"A death in the life of p53","volume":"362","author":"Lane, D.P.","year":"1993","unstructured":"Lane DP. A death in the life of p53. Nature 1993; 362: 786-7.","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/j.1460-2075.1990.tb08279.x","article-title":"Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form","volume":"9","author":"Gammon, J.V.; Greaves, R.; Iggo, R.; Lane, D.P.","year":"1990","unstructured":"Gammon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBOJt 1990; 9: 1595-602.","journal-title":"EMBOJt"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/350427a0","article-title":"Mutational hotspot in the p53 gene in human hepatocellular carcinomas","volume":"350","author":"Hsu, I.C.; Metcalf, R.A.; Sun, T.; Welsh, J.A.; Wang, N.J.; Harris, C.C.","year":"1991","unstructured":"Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-8.","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/350429a0","article-title":"Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa","volume":"350","author":"Bressac, B.; Kew, M.; Wands, J.; Ozturk, M.","year":"1991","unstructured":"Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350: 429-3 1.","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/hep.1840180314","article-title":"Kar 5, Jaffe R, Carr BI. Mutations at codon of p53 gene in human hepatoblastoma","volume":"18","year":"1993","unstructured":"Kar 5, Jaffe R, Carr BI. Mutations at codon of p53 gene in human hepatoblastoma. Hepatology 1993; 18: 566-9.","journal-title":"Hepatology"},{"key":"ref_7","first-page":"145","article-title":"Widespread p53 overexpression in human malignant tumours","volume":"140","year":"1992","unstructured":"Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumours. AmJyPathol 1992; 140: 145-53.","journal-title":"AmJyPathol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon, E.R.; Vogelstein, B.","year":"1990","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000658-199101000-00004","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis","volume":"213","author":"Rosen, C.B.; Nagorney, D.M.; Wiesner, R.H.; Coffey, R.J.; Larusso, N.F.","year":"1991","unstructured":"Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, Larusso NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991; 213: 21-5.","journal-title":"Ann Surg"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2559.1993.tb01223.x","article-title":"Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds","volume":"23","author":"McKee, P.H.; Hobbs, C.; Hall, P.A.","year":"1993","unstructured":"McKee PH, Hobbs C, Hall PA. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology 1993; 23: 377-9.","journal-title":"Histopathology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/39.6.1709656","article-title":"Antigen retrival in formalinfixed, paraffin embedded tissues: an enhanced method for immunohistochemical staining based on microwave over heating of tissue sections","volume":"39","author":"Shi, SR, Key; ME, Lalra; K.L.","year":"1991","unstructured":"Shi SR, Key ME, Lalra KL. Antigen retrival in formalinfixed, paraffin embedded tissues: an enhanced method for immunohistochemical staining based on microwave over heating of tissue sections. J Histochem Cytochem 1991; 39: 741.","journal-title":"J Histochem Cytochem"},{"key":"ref_12","first-page":"1973","article-title":"Abnormal structure and expression of p53 gene","volume-title":"human HCC. Proc Nad Acad Sci","volume":"87","author":"Bressac, B.; Gavin, K.M.; Liang, T.J.; Isselbacher, K.J.; Wands, JR, Ozturk; M.","year":"1990","unstructured":"Bressac B, Gavin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structure and expression of p53 gene in human HCC. Proc Nad Acad Sci USA 1990; 87: 1973-7."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2007-1007302","article-title":"Recent advances in the management of cholangiocarcinoma","volume":"14","author":"Vauthhey, J.N.; Blumgart, L.H.","year":"1994","unstructured":"Vauthhey JN, Blumgart LH. Recent advances in the management of cholangiocarcinoma. Semin Liv Dis 1994; 14: 109-15.","journal-title":"Semin Liv Dis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1056\/NEJM199407073310113","article-title":"Clinical implications of basic research. Cancer therapy meets p53","volume":"331","author":"Kinzler, K.W.; Volgstein, B.","year":"1994","unstructured":"Kinzler KW, Volgstein B. Clinical implications of basic research. Cancer therapy meets p53. N Engl J Med 1994; 331: 49-50.","journal-title":"N Engl J Med"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM199310283291807","article-title":"Clinical implications of the p53 tumour suppressor gene","volume":"329","author":"Harris CC, Hollstein M","year":"1993","unstructured":"Harris CC, Hollstein M. Clinical implications of the p53 tumour suppressor gene. N Engl J Med 1993; 329: 1318-27.","journal-title":"N Engl J Med"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/0092-8674(93)90719-7","article-title":"p53-dependent apoptosis modulates the cytotoxicity of anticancer agents","volume":"74","author":"Lowe, S.W.; Ruley, H.E.; Jacks, T.; Housman, D.E.","year":"1993","unstructured":"Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-67.","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1346476","article-title":"Modulation of activity of the promoter of the human MDR1 gene by Ras and p53","volume":"255","author":"Chin, K.V.; Ueda, K.; Pastan, I.; Gottesman, M.M.","year":"1992","unstructured":"Chin KV, Ueda K, Pastan I, Gottesman MM. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 1992; 255: 459-62.","journal-title":"Science"},{"key":"ref_18","first-page":"249","article-title":"p53 expression in formalin-fixed, paraffin embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections","volume":"7","author":"Terada, T.; Shimizu, K.; Izumi, R.; Nakanuma, Y.","year":"1994","unstructured":"Terada T, Shimizu K, Izumi R, Nakanuma Y. p53 expression in formalin-fixed, paraffin embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections. Mod Pathol 1994; 7: 249-52.","journal-title":"Mod Pathol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/path.1711720104","article-title":"An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasm","volume":"172","author":"Baast, I.O.; Mulder, J.W.R.; Offerhaust, G.J.A.; Vogelstain, B.; Hamilton, SR","year":"1994","unstructured":"Baast IO, Mulder JWR, Offerhaust GJA, Vogelstain B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasm. J Pathol 1994; 172: 5-12.","journal-title":"J Pathol"},{"key":"ref_20","first-page":"1","article-title":"p53 in tumour pathology: Can we trust immunohistochemistry? - Revisited","volume":"172","author":"Hall, P.A.; Lane, D.P.","year":"1994","unstructured":"Hall PA, Lane DP. p53 in tumour pathology: Can we trust immunohistochemistry? - Revisited. J7 Pathol 1994; 172: 1-4."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00000478-198907000-00004","article-title":"Well differentiated cholangiocarcinoma: diagnostic significance of morphologic and immunohistochemical parameters","volume":"13","author":"Nakajima, T.; Kondo, Y.","year":"1989","unstructured":"Nakajima T, Kondo Y. Well differentiated cholangiocarcinoma: diagnostic significance of morphologic and immunohistochemical parameters. Amn J Surg Pathol 1989; 13: 569-73.","journal-title":"Amn J Surg Pathol"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.38.2.265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T12:10:06Z","timestamp":1765627806000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.38.2.265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,2]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1996,2,1]]},"published-print":{"date-parts":[[1996,2]]}},"alternative-id":["10.1136\/gut.38.2.265"],"URL":"https:\/\/doi.org\/10.1136\/gut.38.2.265","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,2]]}}}